| CPC A61B 5/486 (2013.01) [A61B 5/087 (2013.01); A61B 5/097 (2013.01); A61B 5/4839 (2013.01); A61B 5/7405 (2013.01); A61B 5/742 (2013.01); A61B 5/7455 (2013.01); A61K 36/00 (2013.01); A61M 15/08 (2013.01); A61M 21/02 (2013.01); A63B 23/185 (2013.01); A63B 24/0087 (2013.01); A61B 5/0873 (2013.01); A61B 5/0875 (2013.01); A61B 5/0876 (2013.01); A61B 5/0878 (2013.01); A61B 5/09 (2013.01); A61M 2016/0024 (2013.01); A61M 2021/0016 (2013.01); A61M 2205/3334 (2013.01); A61M 2205/502 (2013.01); A61M 2205/583 (2013.01); A61M 2205/8206 (2013.01); A61M 2205/825 (2013.01); A63B 2024/0065 (2013.01); A63B 2024/0068 (2013.01); A63B 2220/805 (2013.01); A63B 2220/833 (2013.01); A63B 2230/405 (2013.01); A63B 2230/435 (2013.01); A63B 2230/505 (2013.01)] | 18 Claims |

|
1. A biofeedback device comprising:
an inlet for receiving exhaled breath from a user's mouth;
a determiner physically associated with a device housing, the determiner functionally associated with the inlet, the determiner configured to determine when the exhaled breath is received by the inlet;
a reporter associated with the determiner, the reporter configured to determine an actual exhalation duration of the exhaled breath and to provide a signal to the user;
an inhalable substance outlet; and
a dispenser associated with the inhalable substance outlet, the dispenser configured to dispense an inhalable substance to the user through the inhalable substance outlet,
wherein the signal comprises a comparison of the actual exhalation duration to a preferred exhalation duration.
|